David C. Smith was named chief medical officer and associate director for cancer clinical services and Shruti Jolly was named associate director for the Michigan Medicine statewide cancer network by the University of Michigan Health Rogel Cancer Center.
Smith, professor of hematology/oncology, is also the associate chief clinical officer for cancer at Michigan Medicine. Jolly, professor of radiation oncology, is the associate chief clinical strategy officer for cancer services at Michigan Medicine.
As chief medical officer and associate director for cancer clinical services, Smith will be charged with promoting and enhancing cancer clinical operations and clinical research opportunities at Rogel cancer care clinics and affiliated sites. He will focus on patient experience, increasing access to clinical research, and enhancing workforce diversification and satisfaction.
Smith joined the U-M faculty in 1996. He specializes in the care of patients with urologic cancers.
Jolly’s role will be to promote and advance a statewide system of cancer care and research. She also serves as the executive director of the Cancer Network of West Michigan, a partnership among Michigan Medicine, University of Michigan Health-West, the Lacks Cancer Center at St. Mary’s, and the Johnson Family Cancer Center at Mercy Muskegon.
Jolly joined the U-M faculty in 2007 and treats patients with thoracic, gynecologic, and endocrine cancers.
